RE:RE:Yesterday's Committee Meeting...Health123, the days of AMCos price gouging will not end with the passage of this legislation. In fact, they ended a long time ago. Price gouging is no longer any part of Concordia's strategy in the UK or elsewhere. It has not been for awhile. This is not only because of the CMA investigation and this pending legislation. Competition has not and does not allow it.
The big gamble with this stock is whether the Company will be able to develop a business model that is not dependent upon unreasonable and unsustainable price increases, and thus to operate with sufficient profitability to meet its long-term debt obligations. If it cannot do so, those shorting to zero will ultimately win, but, in my view, it will be at least a year or two before they get that win, possibly longer. Bankruptcy is not imminent. On the other hand, if the Company can succeed in forging a new business model, longs who bought in at the right price will have a significant victory. Longs who bought in at the stupid highs at which this stock once traded, and who are still in, may see an improvement to their current position, but any hope of the stock going up to even 15 percent of those past highs is a pipe dream.
That is it, plain and simple. It is a gamble. But here is the thing: At least current management seem focussed on the right issues. Past management (including scumbag Kupinsky who is still Chairman) clearly were not. For them it was simply a pump and dump stock play from which they have, for the most part, moved on.